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In an effort to identify a promoter suitable for studying early ocular development, we generated transgenic mice carrying the
lacZ reporter gene linked to the tyrosinase-related protein 2 (TRP2) promoter. TRP2-lacZ was expressed in early retinal
pigment epithelium (RPE) and early neural crest cells in embryos. The promoter activity was robust and consistent in
independent transgenic lines. The transgene was also expressed in the optic nerve and neural crest-derived neuronal cells
in which the endogenous TRP2 gene is not expressed. This suggests that repressor elements may be missing in the promoter
sed in this study. To test whether this promoter can be used to study melanocyte development, we cross-mated TRP2-lacZ
transgenic mice with mice heterozygous for the Patch (Ph) mutation. The pattern of b-galactosidase activity in the embryos
correlates well with the pigmentation phenotype in postnatal and adult Ph/1 mice. We also generated transgenic mice
expressing fibroblast growth factor 9 (FGF9) directed by the TRP2 promoter and examined the effect on ocular development.
Ectopic expression of FGF9 in the early embryonic RPE switched its differentiation pathway to a neuronal fate, resulting in
formation of a duplicated neural retina in transgenic mice. These studies demonstrate that the TRP2 promoter is valuable
for transgenic studies of ocular differentiation and development of neural crest cells. © 1999 Academic PressKey Words: TRP2 promoter; transgenic mice; RPE; neural retina; neural crest cells; melanocytes; Patch mutation.
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Tyrosinase-related protein 2 (TRP2) is an enzyme in-
volved in an intermediate step of melanin synthesis
(Pawelek et al., 1980; Aroca et al., 1990; Tsukamoto et al.,
992). TRP2 isomerizes DOPAchrome to eumelanin 5,6-
ihydroxyindole-5-carboxylic acid. Therefore, TRP2 is also
alled DOPAchrome tautomerase (DCT) (Aroca et al.,
990). TRP2 is encoded at the Slaty locus on mouse
hromosome 14 (Jackson et al., 1992). The sequence of
RP2 from Slaty mice shows a single base (and single
mino acid) difference from the wild type, located within
ne of the putative copper binding sites of the protein
Jackson et al., 1992). This mutation results in three- to
ourfold reduction in DCT activity such that the mice
roduce dark gray/brown rather than black eumelanin.
RP2 expression is detected in pigmented cells in ocular
issues and melanocyte precursors in the mouse embryo
1 To whom correspondence should be addressed at the Depart-
ment of Cell Biology, Baylor College of Medicine, One Baylor Plaza,
Houston, TX 77030. Fax: (713) 790-1275. E-mail: overbeek@
bcm.tmc.edu.
154Steel et al., 1992; Pavan and Tilghman, 1994; Wehrle-
aller and Weston, 1995).
TRP2 is one of the earliest molecular markers for retinal
igment epithelium (RPE) and melanocyte differentiation.
uring mouse embryogenesis, TRP2 is first expressed in the
ptic vesicle at E9.5 (Steel et al., 1992). The region that
expresses this gene is destined to become RPE. The onset of
TRP2 expression precedes the invagination of the optic
vesicle and morphological expansion of neural epithelial
cells in the optic vesicle. This suggests that the TRP2
promoter may be used to target transgene expression to RPE
at the very beginning of ocular differentiation. TRP2 expres-
sion can be detected in melanocyte precursors in E10.5
mouse embryos, 6 days before melanin synthesis begins
(Steel et al., 1992; Cable et al., 1995). Therefore, the TRP2
promoter may also be useful for studying early development
of melanocytes.
To test these possibilities, we generated transgenic mice
carrying a lacZ gene linked to either a 3.7- or a 1.7-kb
mouse TRP2 promoter. The expression patterns of the
TRP2-lacZ transgenes were visualized by assay for
b-galactosidase (b-gal) activity and were compared to the
0012-1606/99 $30.00
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155TRP2 Promoter Activity in Transgenic Miceendogenous TRP2 gene assayed by in situ hybridization
with an antisense riboprobe. The robustness and consis-
tency of transgenic TRP2 promoter activity in ocular and
neural crest-derived tissues suggest that it may be a useful
tool for targeting transgene expression to these tissues. To
determine whether TRP2-lacZ transgenic mice can be used
o study melanocyte development, they were mated with
ice heterozygous for the Patch (Ph) mutation. The pattern
f b-gal-positive melanocyte precursors in the embryos was
onsistent with the pigmentation phenotype in postnatal
nd adult Ph/1 mice.
To test whether the TRP2 promoter can be used to
xpress secreted signaling proteins to influence ocular
evelopment, we generated transgenic mice expressing
broblast growth factor 9 (FGF9) directed by this pro-
oter. Ectopic expression of FGF9 in the early embryonic
PE switched its differentiation pathway to a neuronal
ate, resulting in formation of a second layer of neural
etina in the transgenic mice. These experiments demon-
trate that the TRP2 promoter can be used for transgenic
tudies of ocular differentiation and development of
eural crest cells.
METHODS
Generation and Screening of Transgenic Mice
A 3.7-kb genomic fragment (23290 to 1443 relative to the
FIG. 1. TRP2-lacZ (A) and TRP2-FGF9 (B) DNA constructs. For m
nto a vector with the lacZ gene and SV40 polyadenylation sequen
nd BamHI, yielding 7.4- and 5.4-kb fragments for microinjection.
laI and EcoRI sites of a vector containing the 1.7-kb TRP2 promote
he 3.5-kb microinjection fragment was obtained by digestion witranscription initiation site) from the mouse TRP2 gene (provided
by Drs. P. Budd and I. Jackson) (Budd and Jackson, 1995) was
Copyright © 1999 by Academic Press. All rightexcised from the vector with restriction endonucleases StuI and
stI and used to replace the mouse heat-shock promoter (hsp68) in
he hsp-lacZ-SV40 pA vector (provided by Dr. J. Rossant) (Kothary
t al., 1989). The hsp68 promoter was removed by digestion with
stEII (blunt-ended) and PstI. The DNA fragment for microinjec-
ion was released by digestion with BamHI or SphI and BamHI,
ielding 7.4- and 5.4-kb fragments, respectively (Fig. 1A). These
wo fragments, containing either the 3.7- or the 1.7-kb promoter,
ere separated from the vector backbone by gel electrophoresis and
urified with the Qiaex II DNA purification kit (Qiagen). Both
ragments were injected into one-cell-stage embryos from FVB/N
ice to generate transgenic mice as previously described (Taketo et
l., 1991). Potential founder mice were screened by polymerase
hain reaction (PCR) with genomic DNA extracted from mouse
ails (Robinson et al., 1995). The PCR primers flank a 240-bp
ragment in the lacZ gene (sense, 59-TGG CTG GAG TGC GAT
TT CCT GAG-39; antisense, 59-GCC GAG TTA ACG CCA TCA
AA ATA-39) (Yokoyama et al., 1992). PCR was carried out for 30
ycles using the following conditions: denaturation at 94°C for
0 s, annealing at 60°C for 1 min, and elongation at 72°C for 1 min.
To facilitate preparation of DNA constructs using the TRP2
romoter, we made a vector with multiple cloning sites flanked
pstream by the 1.7-kb TRP2 promoter and downstream by the
.8-kb SV40 small t intron and polyadenylation sequences (SV40
nt-pA) (Lovicu and Overbeek, 1998). A 0.9-kb cDNA encoding
ouse FGF9 (provided by Dr. D. Ornitz) was inserted into the ClaI
nd EcoRI sites of the vector to give rise to the TRP2-FGF9
onstruct (Fig. 1B). The injection fragment was released by diges-
ion with KpnI and NotI. Potential transgenic mice were again
screened by PCR using primers flanking a 0.3-kb fragment from the
SV40 int-pA (sense, 59-GTG AAG GAA CCT TAC TTC TGT GGT
g the TRP2-lacZ construct, a 3.7-kb TRP2 promoter was inserted
SV40 pA). The construct was digested with either BamHI or SphI
the TRP2-FGF9 construct, a 0.9-kb FGF9 cDNA was inserted into
SV40 small t intron and polyadenylation sequences (SV40 int-pA).
nI and NotI.akin
ces (
ForG-39; antisense, 59-GTC CTT GGG GTC TTC TAC CTT TCT
C-39) (Lovicu and Overbeek, 1998).
s of reproduction in any form reserved.
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156 Zhao and OverbeekFIG. 2. TRP2-lacZ expression in mouse embryos at E9.5 (A), E10.5
B), E12.5 (C), and E14.5 (D) assayed by X-Gal staining. (A) Trans-
ene expression was first detected at E9.5 in the dorsal optic vesicle
OV). (B) By E10.5, in addition to expression in the optic cup (OC),
RP2-lacZ was expressed in the forebrain (FB) and in a localized
luster of presumptive migrating neural crest cells (NC). (C) At
12.5, transgene expression was present in many more presump-
ive neural crest cells lateral to the neural tube. Staining in the
orsal root ganglia (DRG) can be seen along the posterior neural
ube. The transgene was also expressed in certain regions of the
idbrain (arrowheads). (D) At E14.5, b-gal-positive cells were
scattered across nearly the entire embryo, with localized aggrega-
tion seen at the eyelid (EL), outer ear (OE), hindlimb (HL), tail (T),
and whisker follicles (WF).
crest cells (NC) were seen migrating into the periocular region.
Endogenous TRP2 was expressed in the RPE and anterior margin
Copyright © 1999 by Academic Press. All rightbetween the neural retina and RPE but not in the optic stalk or
periocular mesenchyme (F). In the E14.5 eye, TRP2-lacZ (G) was
expressed in the RPE, presumptive iris, and ciliary epithelia. Many
melanocyte precursors were present in the eyelid (EL). The endog-
enous gene was expressed in the RPE, eyelid, and neural crest cells
in periocular mesenchyme (H). The labeled neural crest cells near
the RPE may be choroid precursors. Abbreviations: C, cornea; D-V,
dorsal–ventral orientation; L, lens; LP, lens pit; LV, lens vesicle;FIG. 3. Expression of TRP2-lacZ (A, C, E, and G) and endogenous
TRP2 (B, D, F, and H) in the embryonic eye. The red staining in the
in situ hybridization sections (B, D, F, and H) indicates hybridized
35S-labeled antisense riboprobe. At E9.5, both the transgene (A) and
the endogenous gene (B) were expressed in the dorsal optic vesicle
(OV). At E10.5, TRP2-lacZ (C) was expressed in the outer layer of
the optic cup (RPE) and in the optic stalk (OS) while the endoge-
nous gene (D) was expressed only in the presumptive RPE. In the
E11.5 eye, transgene expression (E) was present in the RPE, the
optic stalk, and the anterior margin (AM) of the retina, which will
give rise to the iris and ciliary epithelia. Blue presumptive neuralNR, neural retina; SE, surface ectoderm. Scale bars, 50 mm (A, C),
100 mm (E), and 200 mm (G).
s of reproduction in any form reserved.
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157TRP2 Promoter Activity in Transgenic MiceFIG. 4. Expression of TRP2-lacZ (A, B, C, and E) and endogenous TRP2 (D and F) in nonocular tissues. A transverse section of E11.5
embryonic brain (A) showed that TRP2 promoter activity was present in distal regions of the telencephalic ventricle (TV) and in putative
neural crest cells (arrows). At this stage, many b-gal-positive cells with morphology of neural crest cells had migrated into the regions near
the otic vesicle (OT) (B). Transverse sections of the posterior embryo at E11.5 (C) showed that TRP2-lacZ was expressed in both
dorsolaterally migrating putative melanocyte precursors (MC) and ventrally migrating neural crest cells which have given rise to a variety
of cells including dorsal root ganglia (DRG), sympathetic ganglia (SG), and ventral root Schwann cells (SC). The endogenous TRP2 gene was
xpressed in only a few melanocyte precursors (D). Sections of E14.5 embryonic heads showed that both the transgene (E) and the
ndogenous gene (F) were expressed in melanocyte precursors underneath epidermal epithelium (EE) and in whisker follicles (WF or arrows
n F). Abbreviations: 3rd V, third ventricle; HV, primary head vein; MDA, midline dorsal aorta; ML, motor neuron layer; NCD, notochord;
T, neural tube. Scale bars, 100 mm.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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158 Zhao and OverbeekStaining for b -Gal Activity
To examine the pattern of TRP2-lacZ transgene expression,
transgenic mice were set up to mate with wild-type FVB/N or Ph/1
artners (obtained from The Jackson Laboratory). Timed-pregnant
emale mice or postnatal mice were sacrificed at various stages.
ouse embryos or eyes were collected and subject to X-Gal
5-bromo-4-chloro-3-indolyl b-D-galactoside) staining for b-gal ac-
tivity as previously described (Langford et al., 1991). Mouse tissues
were fixed in 2% paraformaldehyde and 0.2% glutaraldehyde in 0.1
M phosphate buffer (pH 7.3) at 4°C for 1 h. After three 30-min
rinses (in 0.01% sodium deoxycholate, 0.02% NP-40, 2 mM MgCl2,
and 0.1 M phosphate buffer, pH 7.3), b-gal activity was visualized in
X-Gal staining solution (0.1 M phosphate buffer, pH 7.3, 2 mM
MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40, 5 mM potas-
ium ferrocyanide, 5 mM potassium ferricyanide, 1 mg/ml X-Gal).
issues were stained in X-Gal solution at 4°C for 4 to 12 h. Stained
issues were rinsed in phosphate-buffered saline (pH 7.4) and then
tored in 70% ethanol. Heterozygous Ph embryos were identified
y their melanocyte phenotype as previously reported (Wehrle-
aller et al., 1996). After examination and photography of the
verall pattern of transgene expression in the embryo or eye, the
issues were processed in ethanol and Histo-Clear (National Diag-
ostics) and then embedded in paraffin for sectioning. Tissue
ections were counterstained with Nuclear Fast Red (Poly Scien-
ific).
In Situ Hybridization
To determine the expression pattern of endogenous TRP2, we
carried out in situ hybridization using an 35S-labeled antisense
NA probe as previously described (Robinson et al., 1995). Briefly,
he TRP2 plasmid containing the first few hundred bases of
ranscribed sequences (Budd and Jackson, 1995) was linearized by
igestion with restriction endonuclease PmlI. An antisense RNA
robe was synthesized using T3 RNA polymerase in the presence of
35S]UTP. Tissue sections were incubated with hybridization solu-
tion containing the RNA probe. After washes, RNase treatment,
and dehydration, the slides were coated with Kodak NTB-2 emul-
sion for autoradiography. The slides were developed and mounted
with a coverslip and then examined for silver grain distribution
under dark-field illumination. Both the bright- and the dark-field
images were collected by computer through a CCD camera (Leica)
and subsequently superimposed onto each other using PhotoShop
software (Adobe). Silver grains in the dark-field images were
pseudo-colored red to improve contrast in the superimposed im-
ages.
Immunohistochemistry
Mouse eyes were collected on postnatal day 6 (P6) and fixed in
10% formalin overnight at room temperature and then rinsed in
70% ethanol for 24 h. The eyes were next dehydrated using ethanol
solutions of increasing concentration, cleared in xylene, and em-
bedded in paraffin wax. Sections were cut on a microtome, dewaxed
with xylene, and rehydrated using decreasing concentrations of
ethanol. Tissue sections were incubated with 5% normal goat
serum in phosphate-buffered saline (PBS) at room temperature for
15 min to block nonspecific antibody binding. The tissue sections
were then incubated with a monoclonal antibody to rhodopsin
(Barnstable, 1980) at 4°C overnight. After being rinsed with PBS,
the tissue sections were incubated with fluorescein-labeled anti-
mouse IgG (Sigma) at room temperature for 1 h. The slides were
Copyright © 1999 by Academic Press. All rightthen rinsed with PBS and coverslipped in 50% glycerol in PBS for
examination under blue-light illumination. After fluorescent im-
ages were captured using a CCD camera, the tissue sections were
stained with hematoxylin/eosin for histological examination.
RESULTS
Expression of the TRP2-lacZ Transgene
Six transgenic founder mice were obtained with the
7.4-kb TRP2-lacZ construct. Two of them did not express
the transgene and were discarded. Four transgenic founder
mice were generated with the 5.4-kb TRP2-lacZ fragment
nd they all expressed the transgene. All expressing trans-
enic lines showed similar patterns of transgene expression.
TRP2-lacZ transgene expression was first detected at
mbryonic day 9.5 (E9.5) in the dorsal region of the optic
esicle (Figs. 2A and 3A). The expression extended to the
ntire presumptive RPE by E10.5 (Figs. 2B and 3C). At this
tage, TRP2-lacZ started to be expressed in the forebrain
and in migrating individual cells resembling neural crest
cells (NC). E12.5 embryos expressed the transgene in the
eye, the forebrain, certain regions of the midbrain (arrow-
heads), and many neural crest-derived cells lateral to the
neural tube (Fig. 2C). Dorsal root ganglia (DRG) positive for
b-gal activity were present in the posterior region of the
embryo (Figs. 2C and 4C). In E14.5 embryos, in addition to
the eye and forebrain, b-gal-positive cells were seen across
early the entire embryo and were particularly prominent
n the eyelid (EL), outer ear, hindlimb, tail, and whisker
ollicles (WF) (Fig. 2D). Based on the morphology of the
ositive cells, their pattern of interspersion within the
esenchyme, and their localized accumulation within the
mbryo (Figs.4B, 4C, and 4E), most of these cells appear to
e neural crest derived.
Histological sections were prepared to compare patterns
f transgene expression (Figs.3A, 3C, 3E, and 3G) to those of
ndogenous TRP2 expression (Figs. 3B, 3D, 3F, and 3H) in
mbryonic eyes. At E9.5, expression of the TRP2-lacZ
ransgene was present in the dorsal optic vesicle (Fig. 3A),
nalogous to that of endogenous TRP2 (Fig. 3B). In the optic
cup of E10.5 embryos, the transgene was expressed in the
presumptive RPE and in the optic stalk (Fig. 2C). However,
endogenous TRP2 was expressed only in the presumptive
RPE but not in the optic stalk (Fig. 3D). Similar disparities
between the transgene and the endogenous gene were also
observed at later stages. In E11.5 eyes, TRP2-lacZ activity
as present in the RPE, the optic stalk, and the cells of the
nterior margin between neural retina and RPE, which will
ive rise to the iris and ciliary epithelia (Fig. 3E). Many
b-gal-positive cells that appear to be NC derived were
present in the periocular mesenchyme. In contrast, the
endogenous TRP2 gene was expressed only in the RPE and
the anterior margin between neural retina and RPE but not
in the optic stalk or mesenchyme (Fig. 3F). In E14.5 eyes,
the transgene was expressed in the RPE, the presumptive
iris and ciliary epithelia, and a subset of mesenchymal cells
s of reproduction in any form reserved.
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159TRP2 Promoter Activity in Transgenic Micein the EL (Fig. 3G). Endogenous TRP2 was expressed in the
same cells and also in the periocular mesenchyme (Fig. 3H).
The weak staining of RPE and lack of staining in periocular
mesenchyme of the transgenic embryo (Fig. 3G) were likely
due to limited penetration of the X-gal staining solution
into the embryo.
Outside the eye of E11.5 embryos, expression of the
TRP2-lacZ transgene in the distal region of the telence-
phalic vesicle (Fig. 4A) and in tissues near the otic vesicle
(Fig. 4B) is consistent with endogenous TRP2 expression
reported previously (Steel et al., 1992). In addition to its
expression in dorsolaterally migrating cells (putative mela-
nocyte precursors), TRP2-lacZ expression was detected in
ventrally migrating neural crest cells including cells in the
DRG, sympathetic ganglia (SG), and ventral root Schwann
cells (SC) (Fig. 4C) (Weston, 1963; Lumsden, 1988). Trans-
gene expression in dorsal root ganglia along the posterior
neural tube was especially prominent (Figs. 2C and 4C). The
endogenous TRP2 gene, however, was expressed only in a
few dorsolaterally migrating melanocyte precursors (Fig.
4D). No endogenous TRP2 expression was detected in other
neural crest-derived cells such as DRG, SG, or SC. In E14.5
embryos (Figs. 2D and 4E), TRP2-lacZ expression was
present in melanocyte precursors underneath epidermal
epithelium and in developing WF (Fig. 4E). This pattern of
expression was consistent with that of endogenous TRP2
Fig. 4F).
At P3, TRP2-lacZ was expressed in many regions of the
ye including the optic nerve (Fig. 5A). A section of the eye
howed strong expression in the RPE, the pigmented layer
f the ciliary epithelium, iris, choroid, and optic nerve (Figs.
B–5D). In the ciliary body, TRP2 promoter was not active
n the unpigmented ciliary epithelium (Fig. 5D). The pat-
ern of endogenous TRP2 expression (Figs. 5E and 5F) was
imilar to that of the TRP2-lacZ transgene except that the
ndogenous gene was not expressed in the optic nerve. This
s consistent with the observation in embryos that the
RP2-lacZ transgene but not endogenous TRP2 was ex-
ressed in the optic stalk (Fig. 3). In addition, corneal
ndothelial cells appeared to weakly express the TRP2-lacZ
ransgene (Fig. 5D) while they did not express the endoge-
ous TRP2 gene (Figs. 5E and 5F). In adult eyes, expression
atterns of the transgene and endogenous gene were essen-
ially identical to those in P3 eyes (data not shown).
Expression of TRP2-lacZ in Ph/ 1 Embryos
The Ph mutation results in a dominant white spotting
henotype characterized by a depigmented belt around the
bdomen (Gruneberg and Truslove, 1960; Searle and
ruslove, 1970). The Ph mutation is a genomic deletion
hat includes the entire gene encoding the platelet-derived
rowth factor receptor a subunit (Pdgfra) (Stephenson et al.,
1991; Smith et al., 1991). Ph/Ph homozygous embryos
display multiple defects (including small size and abnor-
malities in the somites, heart, and neural tube) and die
around midgestation (Gruneberg and Truslove, 1960;
Copyright © 1999 by Academic Press. All rightorrison-Graham et al., 1992; Schatteman et al., 1992;
rr-Urtreger et al., 1992).
To test whether the TRP2-lacZ transgenic mice can be
sed to study alterations in melanocyte development, these
ice were mated with Ph/1 mice. In E14.5 TRP2-lacZ
ransgenic embryos with no Ph mutation, b-gal1 melano-
cyte precursors were spread over nearly the entire embryo
(Figs. 2D and 6A). However, in Ph/1 embryos, the number
of b-gal1 cells was significantly reduced, even in regions
uch as the outer ear, the eyelid, and the tail (Fig. 6B). This
henotype was particularly prominent in the middle trunk
f the embryo. The apparent absence of melanocyte precur-
ors in this region correlates well with the depigmentation
henotype in the postnatal and adult Ph/1 mice. The thin
lue stripes in 1/1 and Ph/1 embryos may be neural
crest-derived sympathetic neurons or glia (arrows in Figs.
6A and 6B).
Ectopic Neural Retina in TRP2-FGF9
Transgenic Mice
The TRP2-FGF9 construct was injected into one-cell-
stage embryos and some of the recipient females were
sacrificed after 15 days of gestation. Nine potential
transgenic embryos were collected. PCR assays using
primers specific to the SV40 int-pA sequences identified
two embryos carrying the TRP2-FGF9 transgene. In one
of the embryos, the ocular morphology appeared normal.
Subsequent in situ hybridization using an antisense RNA
probe to SV40 pA showed that the TRP2-FGF9 transgene
was not expressed in this embryo (data not shown). In the
other embryo, a striking abnormality occurred in the
eyes. The presumptive RPE was converted to a second
layer of neural retina (Fig. 7A). In the eyes of the
wild-type littermates, RPE was a monolayer of epithelial
cells (Fig. 7B).
Among the injected embryos that were allowed to de-
velop to term, one fertile transgenic male with small eyes
was obtained and mated with a C57BL/6 female. In the eyes
of the transgenic offspring at postnatal day 6, cells in both
the endogenous neural retina and the RPE-derived neural
retina had differentiated and laminated to form three dis-
tinct cell layers, the photoreceptor layer, the intermediate
nuclear layer, and the ganglion cell layer (Fig. 7C). Plexi-
form layers (red and black arrows) can be seen in the
endogenous and the duplicated neural retinae. Immunohis-
tochemical labeling using an antibody to rhodopsin (Barn-
stable, 1980; Zhao and Barnstable, 1996) revealed that cells
on each side of the ventricular zone had differentiated into
photoreceptors (Fig. 7D). This result indicates that FGF
signaling can influence tissue specification during ocular
development and provides a definitive proof that the early
embryonic RPE can be genetically reprogrammed to be-
come neural retina in vivo.
s of reproduction in any form reserved.
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160 Zhao and OverbeekDISCUSSION
Expression Patterns of the TRP2 - lacZ and
Endogenous TRP2
Among the 10 transgenic lines generated with either the
3.7- or 1.7-kb TRP2 promoter, 8 expressed the transgene and
ll showed similar patterns of expression. This indicates
FIG. 5. Expression of TRP2-lacZ by X-Gal staining (A–D) and
expression of endogenous TRP2 by in situ hybridization with an
ntisense riboprobe (E and F) in P3 eyes. An X-Gal-stained P3 eye
A) showed widespread transgene expression in ocular tissues
ncluding the optic nerve (ON). A section of the eye (B–D) showed
hat the transgene was strongly expressed in the RPE, presumptive
igmented ciliary epithelium (PCE), iris (Ir), choroid (Ch), optic
erve, astrocytes (AC) migrating onto the vitreoretinal surface, and
lso weakly in the peripheral corneal endothelium (CE). High-
agnification images of box 1 and box 2 in (B) are shown in (C) and
D), respectively. Expression of endogenous TRP2 (E) in the eye was
early identical to that of TRP2-lacZ (B) except in the optic nerve
nd corneal endothelium which did not express the endogenous
ene (E and F). A high-magnification image of the boxed region in
E) is shown in (F). The pattern of silver grain labeling (black grains
n F) in the iris and ciliary body is the same as b-gal staining in the
transgenic mouse (D). Abbreviations: C, cornea; HV, hyaloid ves-
sels; NR, neural retina; P, pupil; Sc, sclera; UCE, unpigmented
ciliary epithelium. Scale bars, 50 mm (C, D), 100 mm (F), 200 mm (A,
B, E).hat the tissue specificity of transgene expression is intrin-
ic to the TRP2 promoter and independent of the site of
Copyright © 1999 by Academic Press. All rightransgene integration in the genome. In addition, the 1.7-kb
romoter appears to contain the essential regulatory ele-
ents for the tissue specificity. MacKenzie et al. (1997)
ave previously reported use of a 3.6-kb TRP2 promoter to
irect lacZ expression in transgenic mice and to study
elanocyte development in c-Kit mutant embryos. Their
attern of lacZ transgene expression is similar to that
bserved in our transgenic embryos, confirming the consis-
ency of TRP2 promoter activity.
The present and previous studies (Steel et al., 1992; Pavan
nd Tilghman, 1994; Wehrle-Haller and Weston, 1995;
acKenzie et al., 1997) have demonstrated that endoge-
ous TRP2 expression and transgenic TRP2 promoter activ-
ty are restricted to specific tissues derived from neuroec-
oderm and neural crest. The TRP2-lacZ transgene is
onsistently expressed in certain ocular and neural crest-
erived tissues that do not normally express endogenous
RP2. These tissues include the optic stalk (or optic nerve
t later stages), dorsal root ganglia, sympathetic ganglia, and
entral root Schwann cells (Figs. 3–5). These observations
uggest that endogenous TRP2 expression may normally be
epressed in these tissues and that one or more repressor
lements may be missing in the 1.7- and 3.7-kb TRP2
romoters.
It is intriguing that both endogenous TRP2 and TRP2-
acZ genes are expressed in the developing forebrain. Re-
ently, tyrosinase has also been shown to be present in both
ouse and human brain (Tief et al., 1996a,b, 1997, 1998; Xu
t al., 1997). Tyrosinase-related protein 1 (TRP1) promoter
FIG. 6. X-Gal staining of 1/1 and Ph/1 TRP2-lacZ transgenic
embryos at E14.5 (A, B). b-Gal-positive cells were widely spread
across embryos with no Ph mutation (A). In Ph/1 embryos, there
were significantly fewer melanocyte precursors (B). The lack of
blue melanocyte precursors was particularly prominent in the
middle region of the trunk. The positive thin blue stripes may be
neural crest-derived parasympathetic neurons or glia (arrows in A
and B). Abbreviations: EL, eyelid; FB, forebrain; OE, outer ear; T,
tail; WF, whisker follicles.
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cornea; L, lens. Scale bars, 50 mm (D) and 100 mm (A, B).
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Copyright © 1999 by Academic Press. All rightactivity was also observed in many regions of the mouse
brain (Tief et al., 1998). The present study adds to the
increasing evidence that members of the tyrosinase protein
family may play important roles in the nervous system.
Melanocyte Precursors in Ph/1 Embryos
There is a cluster of closely linked coat-color mutations
in the central portion of mouse chromosome 5, including
dominant white spotting (W), Ph, and rump white (Rw)
(Searle and Truslove, 1970). Various alleles of W disrupt the
tructure or expression of the c-Kit receptor tyrosine kinase
Geissler et al., 1988; Duttlinger et al., 1993; Nocka et al.,
990). The function of c-Kit is essential for development of
any cell types including primordial germ cells, hemato-
oietic cells, and melanocytes (Reith et al., 1990; Huizinga
t al., 1995). The Ph mutation is a deletion encompassing
he entire coding region of another tyrosine kinase receptor
ene, Pdgfra (Stephenson et al., 1991; Smith et al., 1991;
Nagle et al., 1994). However, the pigmentation defect in
Ph/1 mice cannot be attributed to haploinsufficiency of
PDGFRa because mice heterozygous for a targeted Pdgfra
null mutation do not display a pigmentation defect (Sori-
ano, 1997). Several studies have suggested that the Ph
deletion alters long-range cis-regulatory elements for the
c-Kit gene and results in misexpression of c-Kit and, there-
fore, an abnormal pattern of pigmentation (Duttlinger et al.,
1995; Wehrle-Haller et al., 1996; Kluppel et al., 1997).
Analysis of melanocyte development in mouse embryos
with Steel, Ph, and W mutations indicates that signaling
through the c-Kit receptor is required for survival and
perhaps dispersal of melanoblasts (Steel et al., 1992; Pavan
and Tilghman, 1994; Cable et al., 1995; Wehrle-Haller and
Weston, 1995; Wehrle-Haller et al., 1996; MacKenzie et al.,
1997). Steel encodes the ligand for c-Kit. A more recent
study showed that the Rw mutation also causes misexpres-
sion of c-Kit (Hough et al., 1998).
In previous studies of melanocyte development in these
mutant mice, expression of the endogenous TRP2 was used
as the marker for melanocyte precursors. These precursor
cells were identified by in situ hybridization with antisense
riboprobes on either tissue sections (Steel et al., 1992; Cable
et al., 1995) or whole-mount embryos (Wehrle-Haller and
Weston, 1995; Wehrle-Haller et al., 1996). The present
study and the earlier report by MacKenzie et al. (1997)
suggest that TRP2-lacZ transgene expression can be used as
a marker for early melanocyte precursors and for studying
melanocyte development in mice with mutations such as
Ph. Visualization of melanocyte precursors by X-Gal stain-
ing of mouse embryos is much more convenient and sensi-
tive than in situ hybridization with riboprobes. A previous
study by Wehrle-Haller et al. (1996) found that melanocyte
precursors expressing TRP2 were present along the dorsal
midline of Ph mutant embryos at E11.5. Our study indi-
cates that by E14.5 these cells have disappeared and haveFIG. 7. Hematoxylin/eosin staining of eye sections from TRP2-
GF9 transgenic and nontransgenic embryos (A, B), and fluorescent
abeling of a P6 eye section using a rhodopsin antibody (D) followed by
ematoxylin/eosin staining (C). In an E15.5 TRP2-FGF9 transgenic
TG) embryo (A), the RPE was converted to a second layer of neural
etina (rNR) while in its nontransgenic (NTG) littermate, the RPE was
monolayer of epithelial cells (B). In TRP2-FGF9 transgenic mice at
6, a high-magnification view of the posterior region of the eye (C)
hows that three neuronal cell layers have formed in both the
ndogenous neural retina (NR) and the rNR. One plexiform layer (red
rrows) separates the ganglion cell layer (G) and the intermediate
uclear layer (I) while another plexiform layer (black arrows) is
eginning to form between the intermediate nuclear layer and the
hotoreceptor layer (P). The pigmented tissue adjacent to the ganglion
ell layer in the rNR is choroid (green arrowhead). Immunofluorescent
abeling with an antibody to rhodopsin indicates that photoreceptor
ells were generated along the ventricular boundary (blue arrows) of
oth retinae (D). Autofluorescence was detected from striated musclenot migrated elsewhere (see Fig. 6B). Our data support the
notion that many melanocyte precursors fail to survive on
s of reproduction in any form reserved.
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are still alive but have stopped expressing TRP2 due to the
absence of a signal required for their normal differentiation.
Targeting Ocular Tissue with the TRP2 Promoter
In vertebrates, the optic vesicle grows out of the diencepha-
lon during early ocular genesis. As the distal portion of the
optic vesicle contacts the surface ectoderm, it starts to invagi-
nate to form a two-layer structure termed the optic cup (Morse
and McCann, 1984). The inner layer becomes the neural retina
while the outer layer becomes the RPE. The anterior margin
between these two layers subsequently gives rise to the iris
and ciliary epithelia (Barnstable, 1991). It is believed that the
early optic vesicle neuroepithelium has equal potential to
become either neural retina or RPE. It is still not known when
and how different regions of the optic vesicle become com-
mitted to a specific differentiation pathway.
It has been previously shown that early embryonic chick
RPE can transdifferentiate to neural tissue when exposed to
FGF1 or FGF2 in vivo (Park and Hollenberg, 1989, 1991;
yer et al., 1998) or in vitro (Pittack et al., 1991; Guillemot
and Cepko, 1992). It has also been shown that the mamma-
lian embryonic RPE is able to transdifferentiate to neural
retina in vitro when stimulated by FGF2 (Zhao et al., 1995,
1997). In the present study, we demonstrate that ectopic
expression of FGF9 using the TRP2 promoter converts the
embryonic RPE from a monolayered cuboidal epithelium to
a second neural retina (Figs. 7A, 7C, and 7D). The second
neural retina forms three distinct cell layers including
photoreceptors, implying that the presence of an RPE is not
required for cell fate determination in the neural retina. Our
results provide further evidence that secreted molecules
such as FGFs may be involved in tissue specification and
differentiation during ocular development (Robinson et al.,
1995; Zhao et al., 1997; Lovicu and Overbeek, 1998).
In summary, we show in this study that the TRP2
promoter can be used to target transgene expression to
certain subsets of neural crest cells and to retinal pigment
epithelial cells during mouse development. The robustness,
consistency and early onset of TRP2 promoter activity
make it a promising tool to manipulate early ocular devel-
opment and differentiation of neural crest cells. The feasi-
bility of such studies has been demonstrated by use of the
TRP2-lacZ transgenic mice to examine melanocyte devel-
opment in mouse embryos with the Ph mutation and by
targeting FGF9 expression to the early RPE thereby convert-
ing it to neural retina.
ACKNOWLEDGMENTS
We thank Drs. P. Budd and I. Jackson for generously providing the
mouse TRP2 genomic DNA, Dr. J. Rossant for the hsp-lacZ vector,
Dr. D. Ornitz for the mouse FGF9 cDNA, Dr. C. Barnstable for
nti-rhodopsin antibody, and A. Volmer and G. Schuster for technical
ssistance. This study was supported by NIH Grants EY10448 and
Y10803, the Knights Templar Foundation, and Fight For Sight, Inc.
Copyright © 1999 by Academic Press. All rightREFERENCES
Aroca, P., Garcia-Borron, J. C., Solano, F., and Lozano, J. A. (1990).
Regulation of mammalian melanogenesis. I. Partial purification
and characterization of a dopachrome converting factor: Dopach-
rome tautomerase. Biochim. Biophys. Acta 1035, 266–275.
Barnstable, C. J. (1980). Monoclonal antibodies which recognise
different cell types in the rat retina. Nature 286, 231–235.
Barnstable, C. J. (1991). Molecular aspects of development of
mammalian optic cup and formation of retinal cell types. Prog.
Retina Res. 10, 45–67.
Budd, P. S., and Jackson, I. J. (1995). Structure of the mouse
tyrosinase-related protein-2/dopachrome tautomerase (Tyrp2/
Dct) gene and sequence of two novel slaty alleles. Genomics 29,
35–43.
Cable, J., Jackson, I. J., and Steel, K. P. (1995). Mutations at the W
locus affect survival of neural crest-derived melanocytes in the
mouse. Mech. Dev. 50, 139–150.
Duttlinger, R., Manova, K., Berrozpe, G., Chu, T. Y., Gyssler, C.,
Zelentz, A. D., Bachvarova, R. F., and Besmer, P. (1993). W-sash
affects positive and negative elements controlling c-kit expres-
sion: Ectopic c-kit expression at sites of kit-ligand expression
affects melanogenesis. Development 118, 705–717.
Duttlinger, R., Manova, K., Berrozpe, G., Chu, T. Y., DeLeon, V.,
Timokhina, I., Chaganti, R., Zelentz, A. D., Bachvarova, R. F.,
and Besmer, P. (1995). The Wsh and Ph mutations affect the c-kit
expression profile: c-kit misexpression in embryogenesis impairs
melanogenesis in Wsh and Ph mutant mice. Proc. Natl. Acad. Sci.
USA 92, 3754–3758.
Geissler, E. N., Ryan, M. A., and Housman, D. E. (1988). The
dominant-white spotting (W) locus of the mouse encodes c-kit
protooncogene. Cell 55, 185–192.
Gruneberg, H., and Truslove, G. M. (1960). Two closely linked
genes in the mouse. Genet. Res. 1, 69–90.
Guillemot, F., and Cepko, C. L. (1992). Retinal fate and ganglion
cell differentiation are potentiated by acidic FGF in an in vivo
assay of early retinal development. Development 114, 743–754.
Hough, R. B., Lengeling, A., Bedian, V., Lo, C., and Bucan, M.
(1998). Rump white inversion in the mouse disrupts dipeptidyl
aminopeptidase-like protein 6 and causes dysregulation of Kit
expression. Proc. Natl. Acad. Sci. USA 95, 13800–13805.
Huizinga, J. D., Thuneberg, L., Kluppel, M., Malyz, J., Mikkelsen,
H. B., and Bernstein, A. (1995). W/kit gene required for intersti-
tial cells of Cajal and for intestinal pacemaker activity. Nature
373, 347–249.
Hyer, J., Mima, T., and Mikawa, T. (1998). FGF-1 patterns the optic
vesicle by directing the placement of the neural retina domain.
Development 125, 869–877.
Jackson, I. J., Chambers, D. M., Tsukamoto, K., Copeland, N. G.,
Gilbert, D. J., Jenkins, N. A., and Hearing, V. (1992). A second
tyrosinase-related protein, TRP-2, maps to and is mutated at the
mouse slaty locus. EMBO J. 11, 527–535.
Kluppel, M., Nagle, D. L., Bucan, M., and Bernstein, A. (1997).
Long-range genomic rearrangements upstream of Kit dysregulate
the developmental pattern of Kit expression in W57 and Wbanded
mice and interfere with distinct steps in melanocyte develop-
ment. Development 124, 65–77.
Kothary, R., Clapoff, S., Darling, S., Perry, M. D., Moran, L. A., and
Rossant, J. (1989). Inducible expression of an hsp68-lacZ hybrid
gene in transgenic mice. Development 105, 707–714.Langford, K. G., Shai, S-Y., Howard, T. E., Kovac, M. J., Overbeek,
P. O., and Bernstein, K. E. (1991). Transgenic mice demonstrate a
s of reproduction in any form reserved.
ST
T
T
T
T
T
W
W
W
X
Y
Z
Z
Z
163TRP2 Promoter Activity in Transgenic Micetestis-specific promoter for angiotensin-converting enzyme.
J. Biol. Chem. 266, 15559–15562.
Lovicu, F. J., and Overbeek, P. A. (1998). Overlapping effects of
different members of the FGF family on lens fiber differentiation
in transgenic mice. Development 125, 3365–3377.
Lumsden, A. (1988). Multipotential cells in the avian neural crest.
Trends Neurosci. 12, 81–83.
MacKenzie, M., Jordan, S. A., Budd, P. S., and Jackson, I. J. (1997).
Activation of the receptor tyrosine kinase Kit is required for the
proliferation of melanoblasts in the mouse embryo. Dev. Biol.
192, 99–107.
Morrison-Graham, K., Schatteman, G. C., Bork, T., Bowen-Pope,
D. F., and Weston, J. A. (1992). A PDGF receptor mutation in the
mouse (Patch) perturbs the development of a non-neuronal
subset of neural crest-derived cells. Development 115, 133–142.
Morse, D. E., and McCann, P. S. (1984). Neuroectoderm of the early
embryonic rat eye. Invest. Ophthalmol. Visual Sci. 25, 899–907.
Nagle, D. L., Martin-DeLeon, P., Hough, R. B., and Bucan, M. (1994).
Structural analysis of chromosomal rearrangements associated
with the developmental mutations Ph, W19H, and Rw on mouse
chromosome 5. Proc. Natl. Acad. Sci. USA 91, 7237–7241.
Nocka, K., Tan, J. C., Chiu, E., Chu, T. Y., Ray, P., Traktman, P.,
and Besmer, P. (1990). Molecular bases of dominant negative and
loss of function mutations at the murine c-kit/white spotting
locus: W37, Wv, W41, and W. EMBO J. 9, 1805–1815.
Orr-Urtreger, A., Bedford, M. T., Do, M. S., Eisenbach, L., and
Lonai, P. (1992). Developmental expression of the a receptor for
platelet-derived growth factor, which is deleted in the embryonic
lethal Patch mutation. Development 115, 289–303.
Park, C. M., and Hollenberg, M. J. (1989). Basic fibroblast growth
factor induces retinal regeneration in vivo. Dev. Biol. 134,
201–205.
Park, C. M., and Hollenberg, M. J. (1991) Induction of retinal
regeneration in vivo by growth factors. Dev. Biol. 148, 322–333.
Pavan, W. J., and Tilghman, S. M. (1994). Piebald lethal (sl) acts
early to disrupt the development of neural crest-derived melano-
cytes. Proc. Natl. Acad. Sci. USA 91, 7159–7163.
Pawelek, J., Korner, A., Bergstrom, A., and Bologna, J. (1980). New
regulators of melanin biosynthesis and the autodestruction of
melanoma cells. Nature 286, 617–619.
Pittack, C., Jones, M., and Reh, T. A. (1991). Basic fibroblast growth
factor induces retinal pigment epithelium to generate neural
retina in vitro. Development 113, 577–588.
Reith, A. D., Rottapel, R., Giddens, E., Brady, C., Forrester, L., and
Bernstein, A. (1990). W mutant mice with mild or severe devel-
opmental defects contain distinct point mutations in the kinase
domain of the c-kit receptor. Genes Dev. 4, 390–400.
Robinson, M. L., Overbeek, P. A., Berran, D. J., Grizzle, W. E.,
Stockard, C. R., Friesel, R., Maciag, T., and Thompson, J. A.
(1995). Extracellular FGF-1 acts as a lens differentiation factor in
transgenic mice. Development 121, 505–514.
Schatteman, G. C., Morrison-Graham, K., van Koppen, A., Weston,
J. A., and Bowen-Pope, D. F. (1992). Regulation and role of PDGF
receptor a-subunit expression during embryogenesis. Develop-
ment 115, 123–131.
Searle, A. G., and Truslove, G. M. (1970). A gene triplet in the
mouse. Genet. Res. 15, 227–235.
Smith, E. A., Seldin, M. F., Martinez, L., Watson, M. L., Choudhury,
G. G., Lalley, P. A., Pierce, J., Aaronson, S., Barker, J., Naylor,
S. L., and Sakaguchi, A. Y. (1991). Mouse platelet-derived growth
factor receptor a is deleted in W19H and Patch mutations on
chromosome 5. Proc. Natl. Acad. Sci. USA 88, 4811–4815.
Copyright © 1999 by Academic Press. All rightoriano, P. (1997). The PDGFa receptor is required for neural crest
cell development and for normal patterning of somites. Devel-
opment 124, 2691–2700.
Steel, K. P., Davidson, D. R., and Jackson, I. J. (1992). TRP-2/DT, a
new early melanoblast marker, shows that Steel growth factor
(c-kit ligand) is a survival factor. Development 115, 1111–1119.
Stephenson, D. A., Mercola, M., Anderson, E., Wang, C. Y., Stiles,
C. D., Bowen-Pope, D. F., Chapman, V. M. (1991). Platelet-
derived growth factor receptor a subunit gene (Pdgfra) is deleted
in the mouse patch (Ph) mutation. Proc. Natl. Acad. Sci. USA 88,
6–10.
aketo, M., Schroeder, A. C., Mobraaten, L. E., Gunning, K. B.,
Hanten, G., Fox, R., Roderick, T., Stewart, C, Lilly, F., Hansen,
C., and Overeek, P. A. (1991). FVB/N: An inbred mouse strain
preferable for transgenic analyses. Proc. Natl. Acad. Sci. USA 88,
2065–2069.
ief, K., Hahne, M., Schmidt, A., and Beermann, F. (1996a).
Tyrosinase, the key enzyme in melanin synthesis, is expressed in
murine brain. Eur. J. Biochem. 241, 12–16.
ief, K., Schmidt, A., Aguzzi, A., and Beermann, F. (1996b).
Tyrosinase is a new marker for cell populations in the mouse
neural tube. Dev. Dyn. 205, 445–456.
ief, K., Schmidt, A., and Beermann, F. (1997). Regulation of the
tyrosinase promoter in transgenic mice: Expression of a
tyrosinase–lacZ fusion gene in embryonic and adult brain. Pig-
ment Cell Res. 103, 153–157.
ief, K., Schmidt, A., and Beermann, F. (1998). New evidence for
presence of tyrosinase in substantia nigra, forebrain and mid-
brain. Mol. Brain. Res. 53, 307–310.
sukamoto, K., Jackson, I. J., Urabe, K., Montague, P. M., and
Hearing, V. J. (1992). A second tyrosinase-related protein, TRP-2,
is a melanogenic enzyme termed DOPAchrome tautomerase.
EMBO J. 11, 519–926.
ehrle-Haller, B., and Weston, J. A. (1995). Soluble and cell-bound
forms of Steel factor activity play distinct roles in melanocyte
precursor dispersal and survival on the lateral neural crest
migration pathway. Development 121, 731–742.
ehrle-Haller, B., Morrison-Graham, K., and Weston, J. A. (1996).
Ectopic c-kit expression affects the fate of melanocyte precursors
in Patch mutant embryos. Dev. Biol. 177, 463–474.
eston, J. (1963). A radiographic analysis of the migration and
localization of trunk neural crest cells in the chick. Dev. Biol. 6,
274–310.
u, Y., Stokes, A. H., Freeman, W. M., Kumer, S. C., Vogt, B. A.,
and Vrana, K. E. (1997). Tyrosinase mRNA is expressed in human
substantia nigra. Mol. Brain Res. 45, 159–162.
okoyama, T., Liou, G. I., Caldwell, R. B., and Overbeek, P. A.
(1992). Photoreceptor-specific activity of the human interphoto-
receptor retinoid-binding protein (IRBP) promoter in transgenic
mice. Exp. Eye Res. 55, 225–233.
hao, S., Thornquist, S. C., and Barnstable, C. J. (1995). In vitro
transdifferentiation of embryonic rat retinal pigment epithelium
to neural retina. Brain Res. 677, 300–310.
hao, S., and Barnstable, C. J. (1996). Differential effects of bFGF on
development of rat retina. Brain Res. 723, 169–176.
hao, S., Rizzolo, L. J., and Barnstable, C. J. (1997). Differentiation
and transdifferentiation of the retinal pigment epithelium. Int.
Rev. Cytol. 171, 225–266.
Received for publication June 4, 1999
Revised August 26, 1999
Accepted September 1, 1999
s of reproduction in any form reserved.
